The Mohammed VI Foundation for Sciences and Health signed a partnership agreement with AstraZeneca. This collaboration aims to develop Centers of Excellence to strengthen the capacities of the Moroccan healthcare system in various areas, including:
Disease pathways and access to innovation for patients in Morocco: By focusing on exploring and understanding the patient journey, this ensures equitable access to innovative medical treatments to enhance health outcomes.
Diagnosis and personalized medicine: Through the implementation of early cancer screening projects and the establishment of necessary diagnostic infrastructures.
Strengthening the skills of medical and paramedical resources: By collaborating to enhance the skills and knowledge of healthcare professionals. This will ensure high-quality and comprehensive care.
Research and data generation, including capacity and utilization of new technologies: By supporting medical research and adopting new technologies, this partnership will contribute to advancing medical knowledge and improving healthcare practices.
Professor Youns BJIJOU, Deputy Director of the Mohammed VI Foundation for Sciences and Health, stated:
“We are delighted with this partnership with AstraZeneca. The Mohammed VI Foundation for Sciences and Health’s mission is to develop research and innovation in the field of health, and we are confident that together we will overcome the challenges in healthcare and contribute to improving the quality of patient care.”
Dr. Amine SEKHRI, General Manager of AstraZeneca Morocco, emphasized with conviction:
“The signing of this agreement reflects our shared commitment to advancing healthcare. We look forward to implementing the initiatives outlined in this agreement and making a significant contribution to medical innovation, both in Morocco and worldwide.”
About the Mohammed VI Foundation for Sciences and Health:
The Mohammed VI Foundation for Sciences and Health is a non-profit institution, honorifically chaired by His Majesty King Mohammed VI. Endowed with legal personality and financial independence, the FM6SS is dedicated to serving the public interest. Its primary objective is to promote medical treatments while fostering the development of education, training, research, and innovation.The FM6SS comprises a set of entities, each contributing to the realization of its missions. These entities include: the Mohammed VI International University Hospital, the Cheikh Khalifa International University Hospital, the Mohammed VI University of Sciences and Health, the Mohammed VI Continuing Education Center, the Mohammed VI Dental Care Center, the Mohammed VI Research and Innovation Center, the Mohammed VI International Simulation Center in Sciences and Health, the Mohammed VI National Laboratory of Medical Analyses, the Mohammed VI Anatomopathology Laboratory, the Mohammed VI Center for Bioequivalence, the Mohammed VI Blood Center, University Residences, the Doctoral Studies Center, and the Mohammed VI High School of Excellence.
About AstraZeneca:
AstraZeneca (LSE/STO/Nasdaq: AZN), a globally renowned biopharmaceutical company, is recognized for its relentless efforts in discovering, developing, and commercializing cutting-edge medicine in various therapeutic areas. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, offering innovative solutions to millions of patients worldwide.
